Log In
BCIQ
Print this Print this
 

CX1739

  Manage Alerts
Collapse Summary General Information
Company RespireRx Pharmaceuticals Inc.
DescriptionPositive allosteric modulator (PAM) of AMPA glutamate receptor (GRIA; GLUR)
Molecular Target AMPA glutamate receptor (GRIA) (GLUR)
Mechanism of ActionAMPA receptor enhancer
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

3

$25.0M

$10.0M

$15.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today